Pharmaceutical Price Regulation Scheme

Department of Health and Social Care written question – answered on 10th September 2018.

Alert me about debates like this

Photo of Liz Twist Liz Twist Labour, Blaydon

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the next Pharmaceutical Price Regulation Scheme sets an ambitious framework for delivering quick patient access to new and clinically-effective medicines.

Photo of Liz Twist Liz Twist Labour, Blaydon

To ask the Secretary of State for Health and Social Care, what steps he is taking in the pharmaceutical price regulation scheme negotiations to ensure that modern cancer therapies are categorised as cost-effective.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

The Government is committed to supporting the United Kingdom life sciences industry and ensuring that patients can access cost-effective innovative medicines and technologies, including cost-effective cancer medicines, at a price the National Health Service can afford. We have been listening to industry feedback and discussing how the medicines market is likely to evolve over the next five years. These discussions have now moved into a more formal phase and are commercially sensitive. The Government will update Parliament if and when agreement is reached.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.